Mitchell Eric Horwitz, MD

Professor of Medicine
Member of the Duke Cancer Institute
Affiliate of the Regeneration Next Initiative
Campus mail 2400 Pratt St Suite 5000, DUMC Box 3961, Durham, NC 27710
Phone (919) 668-1000
Email address mitchell.horwitz@duke.edu

Allogeneic stem cell transplantation using umbilical cord blood grafts; Allogenic stem cell transplantation for Sickle Cell Disease; Prevention of acute graft versus host disease through donor stem cell graft manipulation; Improving immune recovery following alternative donor stem cell transplantation using donor graft manipulation or third party thymus transplantation.

In Their Words

Education and Training

  • Medical Resident, Medicine, Northwestern University, 1992 - 1995
  • M.D., Rush University, 1992

Publications

Maung, Ko K., Benny J. Chen, Ian Barak, Zhiguo Li, David A. Rizzieri, Cristina Gasparetto, Keith M. Sullivan, et al. “Phase I dose escalation study of naive T-cell depleted donor lymphocyte infusion following allogeneic stem cell transplantation.” Bone Marrow Transplant, July 5, 2020. https://doi.org/10.1038/s41409-020-0991-5.

PMID
32624583
Full Text

Scaradavou, A., S. T. Avecilla, J. Tonon, I. Politikos, M. E. Horwitz, J. Kurtzberg, F. Milano, J. N. Barker, and J. N. American Society for Transplantation and Cellular Therapy Cord Blood Special Interest Group. “Guidelines for Cord Blood Unit Thaw and Infusion.” Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation, June 27, 2020. https://doi.org/10.1016/j.bbmt.2020.06.018.

PMID
32599214
Full Text

Foster, Gena G., Michael J. Grant, Samantha M. Thomas, Blake Cameron, Doug Raiff, Kelly Corbet, Gavin Loitsch, Christopher Ferreri, and Mitchell Horwitz. “Treatment with Foscarnet after Allogeneic Hematopoietic Cell Transplant (Allo-HCT) Is Associated with Long-Term Loss of Renal Function.” Biol Blood Marrow Transplant, May 23, 2020. https://doi.org/10.1016/j.bbmt.2020.05.007.

PMID
32450288
Full Text

Saad, Ayman, Marcos de Lima, Sarah Anand, Vijaya Raj Bhatt, Ryan Bookout, George Chen, Daniel Couriel, et al. “Hematopoietic Cell Transplantation, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw 18, no. 5 (May 1, 2020): 599–634. https://doi.org/10.6004/jnccn.2020.0021.

PMID
32519831
Full Text

Hourigan, Christopher S., Laura W. Dillon, Gege Gui, Brent R. Logan, Mingwei Fei, Jack Ghannam, Yuesheng Li, et al. “Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease.” J Clin Oncol 38, no. 12 (April 20, 2020): 1273–83. https://doi.org/10.1200/JCO.19.03011.

PMID
31860405
Full Text

Smith, Patrick J., Meagan Lew, Yen P. Lowder, Kristi Romero, Jill Thompson, Lauren Bohannen, Alyssa Pittman, et al. “Cognitive Impairment in Candidates for Allogeneic Hematopoietic Stem Cell Transplantation.” In Biology of Blood and Marrow Transplantation, 26:S241–S241. ELSEVIER SCIENCE INC, 2020.

Scholars@Duke

Smith, Patrick J., Elena Perea, Jillian Thompson, Brian Wasserman, Lauren Bohannon, Taewoong Choi, Cristina Gasparetto, et al. “Clinical and Neuroimaging Predictors of Post-Transplant Delirium.” In Biology of Blood and Marrow Transplantation, 26:S119–S119. ELSEVIER SCIENCE INC, 2020.

Scholars@Duke

Ramalingam, Sendhilnathan, Sharareh Siamakpour-Reihani, Lauren Bohannon, Yi Ren, Alexander Sibley, Andrew Nixon, Jing Lyu, et al. “Phase II Trial of Pasireotide to Prevent GI Toxicity and Acute Gvhd in Allogeneic HSCT.” In Biology of Blood and Marrow Transplantation, 26:S48–49. ELSEVIER SCIENCE INC, 2020.

Scholars@Duke

Saullo, Jennifer L., Yanhong Li, Julia A. Messina, Jillian Thompson, Tara Dalton, Vinay K. Giri, Shelby D. Reed, et al. “Cytomegalovirus in Allogeneic Hematopoietic Transplantation: Impact on Costs and Clinical Outcomes Using a Preemptive Strategy.” Biol Blood Marrow Transplant 26, no. 3 (March 2020): 568–80. https://doi.org/10.1016/j.bbmt.2019.11.005.

PMID
31712193
Full Text

Pages